SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-069068
Filing Date
2024-06-06
Accepted
2024-06-06 16:05:40
Documents
1
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2416582-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2416582-2_4seq1.xml 4 4004
  Complete submission text file 0001104659-24-069068.txt   5597
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARIAD PHARMACEUTICALS, INC 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Cole Hugh M (Reporting) CIK: 0001604646 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 241025026